Van der Aa, A <br/><br/>
T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.  [electronic resource] 

 -  Clinical and experimental immunology  Jan 2003 
 - 155-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9104 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2249.2003.02019.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adoptive Transfer--methods<br/>Adult<br/>Autoantigens--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cell Division<br/>Clone Cells<br/>Female<br/>Genes, T-Cell Receptor beta<br/>Humans<br/>Lymphocyte Activation<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--cerebrospinal fluid<br/>Myelin Basic Protein--immunology<br/>Pilot Projects<br/>Receptor-CD3 Complex, Antigen, T-Cell--immunology<br/>Receptors, Antigen, T-Cell, alpha-beta--immunology